These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10530705)
1. Penetration and decay of meropenem into the human aqueous humor and vitreous. Schauersberger J; Amon M; Wedrich A; Nepp J; El Menyawi I; Derbolav A; Graninger W J Ocul Pharmacol Ther; 1999 Oct; 15(5):439-45. PubMed ID: 10530705 [TBL] [Abstract][Full Text] [Related]
2. Penetration of imipenem into human aqueous and vitreous humor. Axelrod JL; Newton JC; Klein RM; Bergen RL; Sheikh MZ Am J Ophthalmol; 1987 Dec; 104(6):649-53. PubMed ID: 3500645 [TBL] [Abstract][Full Text] [Related]
3. [Studies of the penetrating ability of fosfomycin into the aqueous humor and vitreous body of the eye]. Philipp W; Kofler J Klin Monbl Augenheilkd; 1986 Sep; 189(3):240-2. PubMed ID: 3784414 [TBL] [Abstract][Full Text] [Related]
4. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810 [TBL] [Abstract][Full Text] [Related]
5. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Hariprasad SM; Mieler WF; Holz ER; Gao H; Kim JE; Chi J; Prince RA Arch Ophthalmol; 2004 Jan; 122(1):42-7. PubMed ID: 14718293 [TBL] [Abstract][Full Text] [Related]
6. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753 [TBL] [Abstract][Full Text] [Related]
7. Vitreous penetration of orally administered gatifloxacin in humans. Hariprasad SM; Mieler WF; Holz ER Trans Am Ophthalmol Soc; 2002; 100():153-9. PubMed ID: 12545689 [TBL] [Abstract][Full Text] [Related]
8. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061 [TBL] [Abstract][Full Text] [Related]
9. Effect of ocular compression on intraocular penetration of systemic ofloxacin. Ugurbas SH; Can M; Koksal M; Dincel A; Bozkurt A; Bayar B Adv Ther; 2007; 24(2):394-401. PubMed ID: 17565931 [TBL] [Abstract][Full Text] [Related]
10. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration. Sakamoto H; Sakamoto M; Hata Y; Kubota T; Ishibashi T Eur J Ophthalmol; 2007; 17(3):372-6. PubMed ID: 17534819 [TBL] [Abstract][Full Text] [Related]
11. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Hariprasad SM; Shah GK; Mieler WF; Feiner L; Blinder KJ; Holekamp NM; Gao H; Prince RA Arch Ophthalmol; 2006 Feb; 124(2):178-82. PubMed ID: 16476886 [TBL] [Abstract][Full Text] [Related]
12. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO Retina; 1998; 18(6):521-5. PubMed ID: 9869460 [TBL] [Abstract][Full Text] [Related]
13. Aqueous and vitreous penetration of levofloxacin after oral administration. Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658 [TBL] [Abstract][Full Text] [Related]
14. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration. Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970 [TBL] [Abstract][Full Text] [Related]
15. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Donnenfeld ED; Perry HD; Snyder RW; Moadel R; Elsky M; Jones H Arch Ophthalmol; 1997 Feb; 115(2):173-6. PubMed ID: 9046250 [TBL] [Abstract][Full Text] [Related]
16. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans. Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948 [TBL] [Abstract][Full Text] [Related]
17. The effect of cataract surgery on ocular levels of topical moxifloxacin. Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780 [TBL] [Abstract][Full Text] [Related]
18. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Vemulakonda GA; Hariprasad SM; Mieler WF; Prince RA; Shah GK; Van Gelder RN Arch Ophthalmol; 2008 Jan; 126(1):18-22. PubMed ID: 18195213 [TBL] [Abstract][Full Text] [Related]
19. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Hariprasad SM; Mieler WF; Holz ER Arch Ophthalmol; 2003 Mar; 121(3):345-50. PubMed ID: 12617704 [TBL] [Abstract][Full Text] [Related]
20. Ocular penetration of N-formimidoyl thienamycin (MK-787) and potentiation by dipeptidase inhibitor (MK-791). Finlay KR; Carlson CL; Chow AW Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1147-9. PubMed ID: 6575970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]